Antibiotic Sensitivity of Staphylococcus intermedius Isolated from Canine Pyoderma

Australian Veterinary Practitioner

Volumn 28, Issue 1, 1998, Pages 10-13

  Mueller, Ralf S ^a   Bettenay, Sonya V ^a   Lording, Peter ^a,b   Dell'osa, Domenic ^a,c  

^a Animal Skin and Allergy Clinic   (Australia)

^b Unit 124   (Australia)

^c PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0040764065     PISSN: 0310138X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. BARRS, V..R., MALIK, R. & LOVE, D.N. (1995). Antimicrobial susceptibility of staphylococci isolated from various disease conditions in dogs: A further survey. Aust. Vet. Practit. 25:37.
2. BAUER, A.W., KIRBY, W.M., SHERRIS, J.S. & TURK, M. (1966). Antibiotic susceptibility testing by a standardised single disc method. Am. J. Clin. Path. 45:493.
3. BELL, A. (1995). Prophylaxis of German Shepherd recurrent furunculosis (German Shepherd pyoderma) using cephalexin pulse therapy. Aust. Vet. Practit. 25:30.
4. HARVEY, R.G., NOBLE, W.C. & FERGUSON, E.A. (1993). A comparison of lincomycin hydrochloride and clindamycin hydrochloride in the treatment of superficial pyoderma in dogs. Vet. Rec. 132:351.
5. HILL, P.B. & MORIELLO, K.A. (1994). Canine Pyoderma. J. Am. Vet. Med. Assoc. 204:334.
6. IHRKE, P.J. (1990). Infectious Diseases of the Dog and Cat. Ed. Greene, C.E., p.72, Saunders, Philadelphia.
7. KOCH, H. & PETERS, S. (1996): Antimicrobial treatment in German Shepherd pyoderma: An open clinical study. Vet. Derm. 7:177.
8. KRUSE, H., HOFSHAGEN, M., THORESEN, S.I. & BREDAL, W.P. (1996). The antimicrobial susceptibility of staphylococcus species isolated from canine dermatitis. Vet. Res. Com. 20:205.
9. LLOYD, D.H., CARLOTTI, D.N., KOCH, H. & HALLIWELL, R.E.W. (1994). Clavulanate-potentiated amoxycillin in the treatment of canine pyoderma: comparison of two dose rates. Proc. No. 11, p.63, Eur. Soc. Vet. Derm., Bordeaux.
10. LLOYD, D.H., LAMPART, A.I. & FEENEY, C. (1996). Sensitivity to antibiotics amongst cutaneous and mucosal isolates of canine pathogenic staphylococci in the United Kingdom 1980-96. Vet. Derm. 7:171.
11. LOVE, D.N. (1989), Antimicrobial susceptibility of staphylococci isolated from dogs. Aust. Vet. Practit. 19:196.
12. MEDLEAU, L., LONG, P.E., BROWN, J. & MILLER, N.H. (1986). Frequency and antimicrobial susceptibility of staphylococcus species isolated from canine pyodermas, Am. J. Vet. Res. 47:229.
13. MESSINGER, L.M. & BEALE, K.M. (1993). A blinded comparison of the efficacy of daily and twice daily trimethoprim-sulfadiazine and daily sulfadimethoxine-ormetoprim therapy in the treatment of canine pyoderma. Vet. Derm. 4:13.
14. MUELLER, R.S., BETTENAY, S.V., & DELL'OSA, D. (1998). Doxycycline in the treatment of canine pyoderma. Aust. Vet. Practit. 28:14.
15. PARADIS, M., LEMAY, S., SCOTT, D.W., MILLER, W.H., WELLINGTON, J. & PANICH, R. (1990). Efficacy of enrofloxacin in the treatment of canine bacterial pyoderma. Vet. Derm. 1:123.
16. REEDY, L.M. (1993). Comparative results of 100 antibiotic sensitivity tests on Staphylococcus intermedius. Proc. No. 9, p.91, Am. Col. Vet. Derm., San Diego.
17. SAIJONMAA-KOLUMIES, L., BOND, R., LAMPORT, A. & LLOYD, D.H. (1994). The effect of clavulanate-potentiated amoxycillin on skin and mucosal carriage of pathogenic staphylococci in healthy dogs. Proc. No. 11, p.62, Eur. Soc. Vet. Derm, Bordeaux.
18. SCOTT, D.W., MILLER, W.H. & WELLINGTON, J.P. (1993). The combination of ormetoprim and sulfadimethoxine in the treatment of pyoderma due to Staphylococcus intermedius in dogs. Can. Pract. 18:29.
19. von HOVE, W., LETTOW, E. & OPITZ, M. (1992). Erfahrungen mit dem Antiinfectivum Enrofloxacin (Baytril) bei Pyodermien von Hund und Katze. Kleintierpraxis. 37:805.